Transpire Bio Achieves Important Corporate Milestone with Dosing of First Human Subject in the Company’s Asthma and ...
WESTON, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated, clinical-stage biopharmaceutical company focused on developing inhaled medicines, today announced the company dosed the first human subject in a study of its inhalation product …